Literature DB >> 8186292

Genetic information and health insurance. Report of the Task Force on Genetic Information and Insurance. NIH/DOE Working Group on Ethical, Legal, and Social Implications of Human Genome Research.

.   

Abstract

One of the ironies in the current health care coverage crisis is that developing more accurate biomedical information could make things worse rather than better. In the current American health care system, information about an individual's risk of disease plays a crucial role for many people in determining access to health care coverage. This link between the likelihood of needing health care and the ability to obtain coverage for that care has the unfortunate result that those most in need may have the greatest difficulty finding affordable health care coverage. New advances in human genetics are transforming medicine by making available increasing amounts of such information about risk. Biomedical science and the delivery of health care are being reshaped by advances in our understanding of human genetics. New insights into health and disease, new diagnostic and prognostic tests and the possibility of new therapies reflect significant investments by the public and by private business and are no longer limited to the uncommon disorders traditionally labeled as "genetic diseases." Among the first products of genetic research is information useful in predicting the likelihood that an individual will develop particular diseases, opening the door both to preventive strategies that we would welcome, such as changes in diet and exercise patterns, and to the unwelcome possibility of genetic discrimination. Injecting information about genetic risks into the current health care system could result in ever more refined risk rating by insurers and ever greater difficulty in finding affordable health care coverage for large numbers of people. At a minimum, people could be discouraged from obtaining genetic information that might be useful in disease prevention and early treatment or for case planning and management because that same information could jeopardize their access to health care coverage in general, or to treatment for a condition excluded from coverage because it was "pre-existing." Under other circumstances people might be compelled to provide genetic information as a condition of obtaining affordable health care coverage. Genetic risk information carries an additional, wider burden because information about an individual's genetic health risks may also be information about the risks of children, parents, brothers, sisters, and other relatives. One suggested approach--providing special protection for genetic information--is unlikely to succeed. This special protection has been suggested because of the relevance of genetic information to family members and its implications for reproductive choices, potential discrimination and stigmatization.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1993        PMID: 8186292     DOI: 10.1089/hum.1993.4.6-789

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  8 in total

1.  Individual, family, and societal dimensions of genetic discrimination: a case study analysis.

Authors:  Lisa N Geller; Joseph S Alper; Paul R Billings; Carol I Barash; Jonathan Beckwith; Marvin R Natowicz
Journal:  Sci Eng Ethics       Date:  1996-01       Impact factor: 3.525

Review 2.  Genetic information and research: emerging legal issues.

Authors:  Roberta M Berry
Journal:  HEC Forum       Date:  2003-03

3.  Integrating Public Health and Deliberative Public Bioethics: Lessons from the Human Genome Project Ethical, Legal, and Social Implications Program.

Authors:  Karen M Meagher; Lisa M Lee
Journal:  Public Health Rep       Date:  2016 Jan-Feb       Impact factor: 2.792

4.  Genetic testing and private insurance--a case of "selling one's body"?

Authors:  D Hübner
Journal:  Med Health Care Philos       Date:  2006

5.  Is GINA worth the wait?

Authors:  Mark A Rothstein
Journal:  J Law Med Ethics       Date:  2008       Impact factor: 1.718

Review 6.  Molecular genetic testing for adult-onset disorders: the evolving laboratory, physician, patient interface.

Authors:  R T Acton
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

7.  Access to health insurance: experiences and attitudes of those with genetic versus non-genetic medical conditions.

Authors:  Nancy E Kass; Amy M Medley; Marvin R Natowicz; Sara Chandros Hull; Ruth R Faden; Laura Plantinga; Lawrence O Gostin
Journal:  Am J Med Genet A       Date:  2007-04-01       Impact factor: 2.802

8.  Medical privacy and the disclosure of personal medical information: the beliefs and experiences of those with genetic and other clinical conditions.

Authors:  Nancy E Kass; Sara Chandros Hull; Marvin R Natowicz; Ruth R Faden; Laura Plantinga; Lawrence O Gostin; Julia Slutsman
Journal:  Am J Med Genet A       Date:  2004-07-30       Impact factor: 2.802

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.